A recent meta-analysis of studies of patients prescribed clopidogrel for ischaemic stroke/TIA found CYP2C19 ROF carriers had an increased risk of recurrent stroke and MACE [118]. This evidence concerns the gene CYP2C19 and stroke disorder.